Concepedia

Geir Noraberg

GN

7

Publications

1.2K

Citations

7

H-Index

2017

Active since

Affiliations

University of Oslo(Current)

Akershus University Hospital

Oslo University Hospital

Diakonhjemmet Hospital

Østfold Hospital Trust

Geir Noraberg is an author at University of Oslo specializing in clinical trials, pharmacotherapy, and health sciences.

Top concepts

Publications per year

2017–2021

7

Publications

7

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

Kristin Kaasen Jørgensen, Inge Christoffer Olsen, Guro Løvik Goll et al. · The Lancet · 2017 · 789 citations

, , +10

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases

Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Guro Løvik Goll et al. · JAMA · 2021 · 147 citations · Full text

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases

Silje Watterdal Syversen, Guro Løvik Goll, Kristin Kaasen Jørgensen et al. · JAMA · 2021 · 117 citations · Full text

Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: open‐label extension of the NOR‐SWITCH trial

Guro Løvik Goll, Kristin Kaasen Jørgensen, J. Sexton et al. · Journal of Internal Medicine · 2019 · 116 citations · Full text

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections—A Scandinavian real-life study

Olav Dalgård, Ola Weiland, Geir Noraberg et al. · PLoS ONE · 2017 · 35 citations · Full text

Rows per page

1–5 of 7